Preparation and evaluation of sucrose stabilized tetanus toxoid encapsulated into chitosan microspheres

Genomic Medicine, Biomarkers, and Health Sciences

Volumn 3, Issue 3-4, 2011, Pages 91-97

  Arthanari, Saravanakumar ^a   Renukadevi, Ponnusamy ^a   Mani, Kavaretti Raju ^b  

^a ANNA UNIVERSITY   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Adjuvant; Biodegradable polymers; Chitosan microspheres; Tetanus toxoid; Vaccine delivery systems

Indexed keywords

ALUMINUM POTASSIUM SULFATE; CHITOSAN; MICROSPHERE; SUCROSE; TETANUS ANTIBODY; TETANUS TOXOID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG RELEASE; EMULSION; ENCAPSULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL GUINEA PIG; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL;

EID: 84860281360     PISSN: 22114254     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gmbhs.2011.10.001     Document Type: Article

References (26)

1. Alonso M.J., Gupta R.K., Min C., et al. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems. Vaccine 1994, 2:299-306.
2. Zhao Z., Leong K.W. Controlled delivery of antigens and adjuvants in vaccine development. J Pharm Sci 1996, 85:1261-1270.
3. Aguado M., Lambert P. Controlled release vaccines: biodegradable polylactide/polyglycolide (PL/PG) microspheres as antigen vehicles. Immunology 1992, 184:113-125.
4. Gupta R.K., Siber G.R. Adjuvants for human vaccines - current status, problems and future prospects. Vaccine 1995, 13:1263-1276.
5. Kohn J., Niemi S.M., Albert E.C., et al. Single step immunization using a controlled release, biodegradable polymer with sustained adjuvant activity. J Immunol Met 1986, 95:31-38.
6. Alpar H.O., Almeida A.J., Brown M.R.W., et al. Immune responses to mucosally administered tetanus toxoid in biodegradable PLA microspheres. Proc Int Cont Rel Bioact Mater 1994, 21:867-868.
7. Gombotz W.R., Wee S.F. Protein release from alginate matrices. Adv Drug Del Rev 1998, 31:267-285.
8. Illum L. Chitosan and its use as a pharmaceutical excipient. Pharm Res 1998, 15:1326-1331.
9. Felt O., Buri P., Gurny R. Chitosan: a unique polysaccharide for drug delivery. Drug Dev Ind Pharm 1998, 24:979-993.
10. Vander Lubben L.M., Verhoef J.C., Borchard G., et al. Chitosans for mucosal vaccination. Adv Drug Deliv Rev 2001, 52:139-144.
11. Read R.C., Naylor S.C., Potter C.W., et al. Effective nasal influenza vaccine delivery using chitosan. Vaccine 2005, 23:4367-4374.
12. Jameela S.R., Mishra A., Jayakrishnan A. Cross-linked chitosan microspheres as carriers for prolonged delivery of macromolecular drugs. J Biomat Sci Polym Edu 1994, 6:621-632.
13. Johansen P., Men Y., Audran R., et al. Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives. Pharm Res 1998, 15:1103-1110.
14. Indian Pharmacopoeia 1985, Ministry of Health and Family Welfare, Government of India, New Delhi, India, 2:A39. 3rd ed.
15. Kreuters J. Nanoparticles and nanocapsules - new dosage forms in the nanometer size range. Pharm Acta Helv 1978, 53:33-39.
16. Shirodkar S., Hutchinson R., Perry D., et al. Aluminum compounds used as adjuvants in vaccines. Pharm Res 1990, 7:1282-1288.
17. Aprile M.A., Wardlaw A.C. Aluminium compounds as adjuvants for vaccines and toxoids in man: A review. Can J Public Health 1966, 57:343.
18. Gupta R.K., Singh M., O'Hagan D.T. Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines. Adv Drug Deliv Rev 1998, 32(3):225-246.
19. Gupta R.K., Siber G.R. Comparison of adjuvant activities of aluminium phosphate, calcium phosphate and stearyl tyrosine for tetanus toxoid. Biologicals 1994, 2:53-63.
20. Horisawa E., Kubota K., Tuboi I., et al. Size-dependency of DL-lactide/glycolide copolymer particulates for intra-articular delivery system on phagocytosis in rat synovium. Pharm Res 2002, 19:132-139.
21. Thile L., Merkle H.P., Walter E. Phagocytosis and phagosomal fate of surface-modified microparticles in dendritic cells and macrophages. Pharm Res 2003, 20:221-228.
22. Desai K.G.H., Kumar T.M. Preparation and evaluation of a novel buccal adhesive system. AAPS Pharm Sci Tech 2004, 5:1-9.
23. Crotts G., Park G. Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues. J Microencapsul 1998, 15:699-713.
24. Perez C., Castellanos I.J., Costantino H.R., et al. Recent trends in stabilizing proteins structure upon encapsulation and release from bioerodible polymers. J Pharm Pharmacol 2002, 54:301-313.
25. Meinel L., Illi O.E., Zapf J., et al. Stabilizing insulin-like growth factor-I in poly(D, L -lactide-co-glycolide) microspheres. J Contr Rel 2001, 70:193-202.
26. Cleland J.L., Barron L., Berman P.W., et al. Development of a single shot sub unit vaccine for HIV-1 and 2. Defining optimal auto boost characteristics the humoral immune response. J Pharm Sci 1996, 85:1346-1349.